Of all the developing countries testing China’s Covid-19 vaccines, few are friendlier to Beijing than Pakistan. In the years leading up to the pandemic, China financed nearly $70 billion across the South Asian nation on roads, railways and power stations, and Pakistan now has two Chinese clinical trials underway, with even senior government officials being inoculated. Yet interviews with people in Karachi, the nation’s biggest city as well as in other developing nations from Indonesia to Brazil, together with surveys and official comments show that China has failed to assure the millions of people who may have to rely on its vaccines.
Foreign Ministry spokesman Zhao Lijian said in a tweet on Monday that Chinese-made vaccines may be the “only choice” for governments that haven’t secured supplies since “wealthy countries” had booked three quarters of the estimated 12 billion vaccines set for production next year. He separately told a briefing that the inactive Chinese vaccines can be distributed more widely than others using existing cold chain systems, and China would provide them to developing countries “on a priority basis including by donation and free aid.”
“We should stand against seeking self-interest at the expense of others or hoarding or monopolizing supplies,” Zhao said in Beijing. “In particular, we must reject vaccine nationalism.”
Sinovac Covid-19 shot more than 50% effective, but data withheld hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
Chinese Sinovac covid vaccine more than 50% effective, but data withheld
A nurse holds China s Sinovac covid vaccine. A 50% efficacy rate is a minimum standard set by US regulators for emergency authorization of Covid vaccines
4 min read
Julia Leite,
, Bloomberg
A Covid-19 vaccine developed by Chinese pharmaceutical firm Sinovac Biotech was found to be more than 50% effective in a Brazilian clinical trial, though researchers delayed releasing more information at the request of the company
Share Via
Read Full Story
A Covid-19 vaccine developed by Chinese pharmaceutical firm Sinovac Biotech Ltd. was found to be more than 50% effective in a Brazilian clinical trial, though researchers delayed releasing more information at the request of the company.
Uganda Allows Chinese Residents to Import Covid-19 Vaccine
A staff nurse at the Royal Cornwall Hospital prepares to administer Covid-19 vaccinations as the hospital began their vaccination programme on Dec. 9 in Truro, United Kingdom. Photo: Bloomberg
(Bloomberg) Uganda approved a request by Chinese residents to import 4,000 doses of a Covid-19 vaccine from their home country for their own use.
The inoculation will be provided to Chinese living in an industrial zone, about 58 kilometers (36 miles) northwest of the capital, Kampala, the Health Ministry said on its Twitter account.
The government “is not importing the Chinese Covid-19 vaccine for use by Ugandans,” the ministry said. The shot has yet to be approved by the World Health Organization, it said.